Durability of ChAdOx1 nCov-19 vaccination in people living with HIV.
Sign Up to like & getrecommendations! Published in 2022 at "JCI insight"
DOI: 10.1172/jci.insight.157031
Abstract: Duration of protection from SARS-CoV-2 infection in people with HIV (PWH) following vaccination is unclear. In a sub-study of the phase 2/3 the COV002 trial (NCT04400838), 54 HIV positive male participants on antiretroviral therapy (undetectable… read more here.
Keywords: chadox1 ncov; sars cov; durability chadox1; vaccination ... See more keywords